Page last updated: 2024-10-28

ibudilast and Vomiting

ibudilast has been researched along with Vomiting in 2 studies

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research Excerpts

ExcerptRelevanceReference
"Ibudilast was generally well tolerated."2.73Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. ( Chang, E; Davidson, JB; Gibbons, JA; Gross, MI; He, L; Johnson, KW; Jones, D; Rolan, P; Sanftner, LM, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Peng, T1
Qi, B1
He, J1
Ke, H1
Shi, J1
Rolan, P1
Gibbons, JA1
He, L1
Chang, E1
Jones, D1
Gross, MI1
Davidson, JB1
Sanftner, LM1
Johnson, KW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471]Phase 3400 participants (Anticipated)Interventional2021-12-22Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for ibudilast and Vomiting

ArticleYear
Advances in the Development of Phosphodiesterase-4 Inhibitors.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Development; Drug Discovery; Humans; Mol

2020

Trials

1 trial available for ibudilast and Vomiting

ArticleYear
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:6

    Topics: Adolescent; Adult; Aged; Chronic Disease; Diabetic Neuropathies; Dose-Response Relationship, Drug; D

2008